Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-001161·Sarepta Therapeutics, Inc.
Schedule 13G ownership disclosure
Sarepta Therapeutics Inc
Common Stock · CUSIP: 803607100
Event date: 2025-08-29
- Filing-level shares
- 10,641,733
- Percent of class
- 10.89%
- The Vanguard Group
Shares: 10,641,733 · Class: 10.89%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-001161
- Form type
- SCHEDULE 13G/A
- Filer
- Sarepta Therapeutics, Inc.
- CIK
- CIK 873303
- Filed
- Sep 08, 2025
- Reporting period
- Aug 29, 2025
- Description
- Schedule 13G beneficial ownership